Genovese Burford & Brothers Wealth & Retirement Plan Management’s Aerie Pharmaceuticals AERI Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-472	Closed	-$32K	–	403
2018 Q2	$32K	Hold	472	–	–	0.01%	216
2018 Q1	$26K	Hold	472	–	–	0.01%	223
2017 Q4	$26K	Hold	472	–	–	0.07%	126
2017 Q3	$22K	Hold	472	–	–	0.01%	217
2017 Q2	$24K	Sell	472 -2,200	-82%	-$102K	0.01%	199
2017 Q1	$122K	Sell	2,672 -2,972	-53%	-$133K	0.05%	89
2016 Q4	$214K	Sell	5,644 -2,500	-31%	-$94.5K	0.06%	63
2016 Q3	$307K	Hold	8,144	–	–	0.12%	45
2016 Q2	$143K	Hold	8,144	–	–	0.06%	78
2016 Q1	$99K	Hold	8,144	–	–	0.05%	91
2015 Q4	$198K	Buy	+8,144	New	+$190K	0.1%	48

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's AERI Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2018, closing a stake of 472 shares — an estimated $32K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in AERI in Q4 2015 and held it in 11 quarters. The position peaked at $307K in Q3 2016. 176 funds tracked by Wall St. Rank hold AERI as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Aerie Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 472 Aerie Pharmaceuticals shares in Q3 2018, an estimated $32K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Aerie Pharmaceuticals in Q4 2015 and held it in 11 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Aerie Pharmaceuticals position peaked at $307K in Q3 2016.
176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.